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Multi-photon intravital imaging has become a powerful tool to investigate the healthy
and diseased brain vasculature in living animals. Although agents for multi-photon
fluorescence microscopy of the microvasculature are available, issues related to stability,
bioavailability, toxicity, cost or chemical adaptability remain to be solved. In particular,
there is a need for highly fluorescent dyes linked to particles that do not cross the blood
brain barrier (BBB) in brain diseases like tumor or stroke to estimate the functional blood
supply. Plant virus particles possess a number of distinct advantages over other particles,
the most important being the multi-valency of chemically addressable sites on the particle
surface. This multi-valency, together with biological compatibility and inert nature, makes
plant viruses ideal carriers for in vivo imaging agents. Here, we show that the well-known
Tobacco mosaic virus is a suitable nanocarrier for two-photon dyes and for intravital
imaging of the mouse brain vasculature.
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INTRODUCTION
Viruses are intensely studied since Tobacco mosaic virus (TMV) was found to be the causing agent
of mosaic disease in tobacco (Harrison and Wilson, 1999; Scholthof, 2008). For the vast majority
of the about 130 years after this finding, plant viruses have been investigated with the aim to
understand and control virus-induced diseases in agricultural crops. As a result of these studies
we have learned about the mechanisms of the disease processes and the fundamental nature of
viruses, including the composition and structure of the viral particles, the viral replication cycle,
and important virus:host interactions (e.g., Zaitlin and Palukaitis, 2000; Ding and Voinnet, 2007;
Heinlein, 2015). Since about 30 years, plant viruses are also objects of biotechnological approaches,
which led to a broad range of applications, from crop improvement to protein production systems.
Plant virus systems have been particularly attractive for the production of recombinant proteins,
including biopharmaceuticals, vaccines, and industrial proteins (Scholthof et al., 1996; Pogue et al.,
2002; Cañizares et al., 2005; Grill et al., 2005; Gleba et al., 2007). The rod-shaped TMV and the
icosahedral Cowpea mosaic virus (CPMV) are among the major vectors for plant-supported mass
production of therapeutic peptides and proteins (Haynes et al., 1986; Gallie et al., 1987; Turpen,
1999; Smith et al., 2009; Sainsbury et al., 2010).
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More recently, plant and other viruses became recognized
as useful templates and building blocks for the development
of nanotechnological applications (Steinmetz, 2010). The size
of viral particles indeed falls into the nanometer range and
thus they can be used for a variety of applications to create
novel nano-sized materials with distinct properties. For example,
the rod-shaped particles of TMV can be used as templates for
mineralization and metallization reactions and the fabrication
of highly ordered hybrid materials, even functional devices and
ferrofluids (Dujardin et al., 2003; Flynn et al., 2003; Suci et al.,
2006; Tseng et al., 2006; Wu et al., 2010; Atanasova et al., 2011;
Chen et al., 2011; Lee et al., 2012). Moreover, since virus-derived
nanoparticles represent naturally occurring nanomaterials that
are both biocompatible and biodegradable, they are also being
developed for biomedical applications. Here, plant viruses are
particularly attractive since, unlike animal or human viruses,
they do not cause diseases in humans. To establish the desired
properties for biomedical use, viral nanoparticles (VNPs) can
be designed and engineered using both genetic and chemical
protocols. By both chemical and genetic manipulation, the viral
coat can be tailored to a desired cell or tissue type, imaging
modality, or therapeutic cargo. Its multivalent nature enables the
incorporation of multiple functionalities, for example targeting
ligands and imaging agents, on a single platform (Young et al.,
2008), which may lead to potential applications in targeted
imaging and therapy (Steinmetz, 2010).
The molecular structure and the biophysical properties of
the rod-shaped TMV particle are well known (Alonso et al.,
2013). The particle is about 300 nm in length and 18 nm in
diameter, with a 4-nm wide inner channel. It has a mass of
39600 kDa and consists of 2130 viral coat protein (CP) subunits
encapsidating a 6.7 kb long RNA in a helical arrangement. The
CP consists of 158 amino acids and has a calculated mass of
17623.7 Da. Each CP subunit offers several accessible sites for
chemical modification at the outer and inner surfaces and the
possibility of insertion of peptides for surface display without
necessarily affecting assembly or infectivity of the virus (e.g.,
Haynes et al., 1986; Fitchen et al., 1995; Smith et al., 2009).
Virus particles can be purified in high yields from plants and are
exceptionally stable allowing derivatization over a broad range
of pH (3.5–9) and temperature (up to 90◦C) in the presence of
solvents such as ethanol or dimethyl-sulfoxide (Alonso et al.,
2013). The virus particle readily assembles in vitro (Fraenkel-
Conrat and Williams, 1955; Okada, 1986; Butler, 1999) with a
short stretch of 432 nucleotides of its RNA (OAS, origin-of-
assembly) being sufficient for assembly (Sleat et al., 1986). In
the absence of RNA, the CP assembles into a 20 S nanoparticle
or “disk,” which represents an assembly intermediate consisting
of 34 CP subunits (Klug, 1999). Thus, CP monomers carrying
different functional groups can be in vitro assembled into disks
or particles of any desired length. Themultivalent nature of TMV
may offer the possibility for developing theranostic particles
in which targeting and imaging capabilities are combined and
which are designed for both the diagnosis and the treatment of
diseases.
The capacity for the application of nanoparticles in the
imaging and diagnosis of tissue alterations related to diseases
depends on the use of fluorochromes and microscopes
compatible with deep tissue imaging. This technology has
been achieved with the development of two-photon (TP) laser
scanning microscopy (TPLSM; Denk et al., 1990; Rubart, 2004)
and of fluorophores optimized for two-photon absorption (TPA;
Lincker et al., 2005; Pawlicki et al., 2009; Massin et al.,
2013). TPLSM employs the excitation of fluorophores by
photons in the infrared region for which biological material
is transparent (Helmchen and Denk, 2005). Moreover, TPLSM
produces background-free images with reduced photobleaching
and photodamage since the simultaneous absorption of the two
photons required for excitation is intrinsically restricted to the
focal point of the excitation beam due to the non-linear nature of
TPA (Rubart, 2004).
Here, we report the production of TMV particles carrying
a two-photon fluorophore and their application as VNPs
in intravital imaging of the mouse brain vasculature. The
fluorescent signal emitted from the VNPs is stable and does not
show any leakage into the surrounding tissues. The particles may
have potential to contribute to the noninvasive detection and
visualization of pathological alterations in the brain vasculature.
MATERIALS AND METHODS
BF3 Synthesis
BF3-NCS has been prepared as described (Hayek et al., 2007a).
BF3-NCS differs from compounds described in Hayek et al.
(2007a) only by a shorter length of the oligoethylene glycol
chains. The physico-chemical properties of BF3-NCS are: 1H-
NMR, CDCl3; (δ ppm): 7.67–7.68 (dd, 2H, J1 = 0.88Hz, J2 =
8.33Hz), 7.50–7.46 (m, 4H), 7.11 (s, 2H), 7.06 (s, 2H), 6.80 (s,
2H), 6.78 (s, 2H), 4.24 (t, 4H, J = 4.8Hz), 4.18 (t, 2H, J = 4.8Hz),
4.03 (t, 2H, J = 6,3Hz), 3.92 (s, 6H), 3.89 (t, 4H, J = 4.8Hz),
3.87–3.64 (m, 22H), 3.57–3.54 (m, 6H), 3.38 (s, 3H), 3.37 (s, 6H),
2.04–1.85 (m, 8H), 0.70 (s, 10H). 13C-NMR, CDCl3; (δ ppm):
152.75; 152.37; 151.49; 140.58; 140.47; 138.32; 137.50; 136.68;
136.18; 136.10; 133.34; 133.06; 128.79; 128.68; 127.86; 127.74;
125.59; 120.62; 119.85; 106.19; 105.37; 103.44; 77.18; 72.37; 72.07;
71.92; 71.90; 71.89; 70.80; 70.74; 70.68; 70.66; 70.54; 70.51; 70.50;
70.45; 69.75; 68.83; 68.73; 58.99; 56.06; 55.93; 44.79; 26.99; 26.85;
17.15; 14.48. C63H87NO15S HRMS: m/z 1129.57952 (calc. m/z
1129.57963).
Isolation of TMV Particles
TMV particles were purified as described previously (Niehl et al.,
2012). Briefly, leaves of TMV-infected Nicotiana benthamiana
plants were ground in liquid N2 to fine powder. After addition
of 10mM sodium-phosphate buffer pH 7.2 containing 0.1%
2-mercaptoethanol, the viral particles were extracted with 1
volume of butanol/chloroform (1:1), precipitated with 4%
polyethylene glycol (PEG) 8000, resuspended in 10mM sodium-
phosphate buffer pH 7.2 and cleared by centrifugation at
5000 × g for 10min. After two cycles of precipitation in 4%
PEG and clearance, the particles were resuspended in 10mM
sodium-phosphate buffer pH 7.2 and stored at −20◦C until
further use.
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Dye Coupling and Purification of TMV-BF3
300µg of the purified viral particles permg BF3-NCS dye
were suspended in a sodium-phosphate buffer pH 7.2—DMSO
mixture (3:1V/V) and incubated in the dark at room temperature
for 1.5 days. After coupling, the TMV-BF3 particles were
separated from unbound dye and concentrated by centrifugation
through Microcon YM-10 size exclusion columns (Millipore)
using the manufacturer’s instructions. The quality and quantity
of the concentrated TMV-BF3 particles was assessed by
transmission electron microscopy (TEM) following staining with
2% uranyl acetate and by SDS polyacrylamide electrophoresis
(SDS-PAGE) using 15% SDS-polyacrylamide gels. Gels were
imaged under UV light using an Ettan DIGE imager (GE
Healthcare) equipped with a Sypro2 (excitation 390/20 nm;
emission 595/25 nm) filter. After imaging, gels were stained with
R250 Coomassie brilliant blue.
Photometric Measurements
All UV-visible absorption spectra were recorded on a Hitachi
U3000 spectrophotometer in a dual beam mode using a matched
pair of 1 × 1 cm quartz cells. Pure solvent was used as reference.
Fluorescence emission spectra were measured with optically
dilute solutions (Abs. < 0.15) in 1 × 1 cm cells using a Photon
Technology International, Inc. (PTI) spectrofluorimeter.
Two-Photon Absorption (TPA)
Measurements
The TPA cross-section spectra were obtained by up-converting
fluorescence using a neodymium-doped yttrium aluminum
garnet Nd:YAG-pumped optical parametric oscillator that
produces 2.6 ns [full width at half maximum (FWHM)] pulses
for excitation in the 450–650 nm spectral range and a Ti:sapphire
femtosecond laser for excitation in the 700–900 nm range.
This set-up does not allow TPA measurements between 650
and 700 nm. The excitation beam was collimated over the
spectrophotometric cell length (10mm). The fluorescence, was
collected at 90◦ of the excitation beam and focused into an optical
fiber connected to a spectrometer. The incident beam intensity
was adjusted to ensure an intensity-squared dependence of the
fluorescence over the whole spectral range. Calibration of the
spectra was performed with p-bis(o-methylstyryl)benzene, for
which the TPA cross section σ2 is 70 GM (Göppert-Mayer) at
570 nm (1 GM = 10−50 cm4 s / photon), and with Rhodamine
B, for which the TPA spectrum at 700–900 nm is known (Xu and
Webb, 1996).
Two-Photon Fluorescence Correlation
Spectroscopy (TP-FCS)
TP-FCS was performed with a home-built setup. TP excitation
was provided by a Tsunami Ti:sapphire laser pumped with a
Millennia V solid-state laser (Spectra-Physics, Mountain View,
CA). 80 Mhz pulses of 100 fs were applied with a wavelength
of 760 nm. Following passage through a beam expander, the
infrared light was focused into the sample by a water-immersion
Olympus objective (60×, NA = 1.2) mounted on an Olympus
IX70 inverted microscope. The back aperture of the objective
was slightly overfilled, creating a diffraction-limited focal spot.
The sample and the reference dye were placed in eight wells
of a Lab-Tek chambered cover glass (Nalge Nunc International,
Rochester, NY) positioned in the X and Y directions by a
motorized stage (Märzhäuser, Germany). The fluorescence from
the samples was collected through the same objective and
directed by a COWL750 dichroic mirror (Coherent, Orsay,
France) toward a 50µm diameter optical fiber coupled to an
avalanche photodiode (SPCM 200 FC, EG&G, Canada). Residual
infrared light was rejected by a BG39 Filter (Coherent). For FCS
measurements, the normalized autocorrelation function (ACF),
G(τ), of the fluorescence intensity fluctuations was calculated
online by an ALV5000E digital correlator card (ALV, Langen,
Germany). Calibration of the systemwas performedwith a 50 nM
tetramethylrhodamine (TMR) solution. Assuming a diffusion
constant of 2.8 × 10−10 m2 s−1 (Clamme et al., 2003), the
equatorial (r0) and axial (z0) radii of the focal volume were,
respectively, 0.29 and 1.3µm, giving an effective volume of 0.2 fL.
Assuming a three-dimensional Gaussian distributed excitation
intensity, the ACF curve for our sample was fitted as described
by Clamme et al. (2003). The fitting curve for our sample
corresponded to a bi-exponential function (y = Aeax+b +
Becx+d), thus reflecting the presence of two different species with
very distinct molecular weights (BF3-coupled virus particles and
free BF3 dye) in the solution.
In vivo Two-Photon Laser Scanning
Microscopy (TPLSM)
In accordance with the policy of Grenoble Institute of
Neuroscience (GIN) and the French legislation, experiments
were done in compliance with the European Community
Council Directive of November 24, 1986 (86/609/EEC). The
research involving animals was authorized by the Direction
Départementale des Services Vétérinaires de l’Isère—Ministère
de l’Agriculture et de la Pêche, France and the Direction
Départementale de la protection des populations—Préfecture de
l’Isère-France (F. Appaix, PhD, permit number 38 09 39). All
efforts were made to minimize the number of mice used and
their suffering during the experimental procedure. CD1 Mice
were housed in cages with food and water ad libitum in a 12 h
light/dark cycle at 22± 1◦C.
For in vivo TPLSM, the 4 months old CD1 mouse in the
experiment was anesthetized using isoflurane (5% for induction
and 1–2% during experiments) in a 70% air, 30% O2 gas mixture.
Its body temperature was monitored with a rectal probe and
maintained at 36◦C using a heating blanket. The MouseOx
system (STARR Life Sciences Corp.) was used for monitoring
arterial O2 saturation, as well as the heart beat and breathing rate.
A catheter (NeoflonTM, BD, USA) was inserted in the tail vein
for intravenous (iv) injection of 100µL of TMV-BF3 (50 mg/mL)
in saline just before the imaging experiments. Sulphorhodamine
B was diluted to 10 mg/mL in saline and 0.1mL was injected
1 h after the iv injection of TMV-BF3 in order to control if the
fluorescent TMV particles addressed the same brain microvessels
as observed by small conventional dyes like Sulforhodamine B.
For intravital two-photon imaging of the cerebral vasculature,
a craniotomy of 2–3mm in diameter was performed with a
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surgical drill above the motor cortex and filled with ultrasound
gel (the head was fixed in a homebuilt stereotactic frame).
TPLSM was performed using a LSM 7 MP (Zeiss, Germany)
equipped with a 20x water-immersion objective (NA 1.0; Zeiss)
and ZEN 2010 software. The blue fluorescence light emission
of the TMV-BF3 particles and the red fluorescence of the
sulforhodamine B dye were simultaneously collected in the
epifluorescence configuration using two photomultiplier tubes
with a FF01 492/SP25 nm filter (Semrock, US) in front of the
“blue PMT” and a FF01 617/73 nm filter (Semrock, US) in front
of the “red PMT.” Laser excitation was performed at 800 nm
using a Ti:Sapphire laser (Chameleon Vision II; Coherent, UK).
All the TPLSM images were obtained with less than 50mW
laser power at the cortical surface. Most 3D TPLSM images were
acquired as z-stacks with 607 × 607µm size x-y direction and
2µm step sizes between each z-focus plane. The 3D projections
were performed with Fiji software (http://fiji.sc/Fiji) using the
in-built “Z-Project” feature (http://fiji.sc/Z-functions) and the
standard deviation projection method.
RESULTS
Preparation of BF3-Coupled TMV Particles
TMV particles isolated from infected Nicotiana benthamiana
plants were coupled to BF3-NCS (Hayek et al., 2007a), a
derivative of the two-photon-excitable fluorophore BF3 (Hayek
et al., 2006; Figure 1A), a non-toxic molecule emitting blue
fluorescence with an improved fluorescence quantum yield
of 73% in water. BF3-NCS carries long oligoethyleneglycol
side chains to provide increased water solubility and an iso-
thiocyanate group (NCS) for chemical coupling (e.g., to −NH2
and −OH groups, i.e., the NH2 group at the N-terminus or
the −OH group of tyr 139 of CP). As a one-dimensional (1D)
conjugated molecule of the general symmetrical D–conjugated pi
system–D (D = electron donor group) structure, it shows a high
TPA cross-section (Figure 1D).
Before conjugation, virus particles were purified from TMV-
infected plants. The purity of the viral particle preparation
was assessed by SDS-PAGE. The particles were then conjugated
to BF3-NCS in a water/DMSO mixture for 36 h and purified
by size exclusion centrifugation. As compared to the colorless
solution that contains viral particles before coupling or the
pale-yellow color of the solution containing coupled but non-
purified particles, the solution containing the concentrated
BF3-coupled viral particles was characterized by a strong
yellow color (Figure 1B) and showed intense blue fluorescence
in UV light. Following coupling and purification, the viral
particle preparation maintained infectivity as was verified by
the observation of local cell death lesions forming on leaves of
hypersensitive Nicotiana tabacum NN tester plants (not shown).
The typical rod-like shape and size dimension of the TMV
particles was not affected by BF3-coupling as was confirmed by
electron microscopy (EM; Figure 1C). 1-photon absorption and
fluorescence emission spectra of the BF3-conjugated particles
showed maxima at 382 and 452 nm, respectively. Moreover, the
absorption was in agreement with the two-photon absorption
peak of the free dye (Figure 1D). These values are similar to the
spectra previously reported for the parent BF3 molecule (Hayek
et al., 2007b). Analysis of the purified particles by SDS-PAGE
revealed a fluorescent protein band running at higher molecular
weight (approximately 18.5 kD) than the normal CP (17.6
kD), thus confirming successful conjugation (Figures 1E,F).
The two-photon sensitivity as well as the purity of fluorescent
particles were verified by two-photon fluorescence correlation
spectroscopy (TP-FCS), which showed a long diffusion time of
0.75ms corresponding to the labeled viral particle (>95%) and a
shorter time of 0.024ms, which corresponds to free dye (<5%)
(Figure 1G).
Application of TMV-BF3 Particles for
Intravital Imaging
To determine the applicability of the dye-conjugated particles
for in vivo TPLSM imaging, we injected 100µL of the particle
solution [50 mg/mL in saline (0.9% NaCl)] into the tail vein
of an anesthetized 4 months-old CD1 mouse placed on the
microscope stage and prepared by craniotomy.We then observed
the cerebral vasculature at the surface of the motor cortex by
TPLSM using a high numerical aperture, 20x water immersion
objective and an excitation wavelength at 800 nm. The cerebral
vasculature was readily visible by strong fluorescence with no
obvious evidence for leakage until 1.5 h after iv injection (see
Figures 2A,B). In previous studies (Hayek et al., 2007b), the
free fluorescent dye diffused freely across the BBB in an 8
months old mouse within 20min after injection. Acquisitions of
z-stacks were used to reconstruct 3D animations that provide
detailed views of the brain vasculature (Movie 1). To verify
the pattern of blood vessels seen with TMV-BF3 by a different
staining, the same mouse was post-injected (1 h after injection
of TMV-BF3) into the tail vein with 100µl of a sulforhodamine
B solution (10 mg/mL). As shown in the overlay Figure 2B,
at 1.5 h post-injection the pattern of vessels labeled with
the red fluorescent dye (red) overlapped with the pattern of
vessels labeled with TMV-BF3 (blue). However, there were also
important exceptions of vessels that were labeled with TMV-BF3
but not or, only weakly, with sulforhodamine B (e.g., the vessel
highlighted by arrows). This observation indicates that the TMV-
BF3 particles partly blocked the blood perfusion in small brain
vessels.
DISCUSSION
Our observations demonstrate that TMV particles labeled with
a multi-photon absorbing fluorochrome can be used as a
blood pool dye for deep tissue vascular imaging. Current
agents for vascular imaging are based on liposomes, quantum
dots, dextrans, lectins, antibodies, iron oxide particles, and
nanospheres. Although each particle type has certain advantages,
diverse problems in relation to stability, bioavailability, toxicity,
chemical flexibility, and cost exist (Lewinski et al., 2008; Cheng
et al., 2012; Adjei et al., 2014). Moreover, inorganic synthetic
particles tend to aggregate and may cause toxic effects under
physiological conditions (Kirchner et al., 2005). TMV particles
represent natural materials that are both biocompatible and
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FIGURE 1 | Production and analysis of TMV-BF3 particles. (A) Molecular formulae of BF3 and BF3-NCS. (B) Solutions containing purified TMV-particles before
coupling (left), non-purified TMV particles after coupling (middle), and TMV particles size-purified after coupling (right). (C) EM image showing integrity of TMV particles
after coupling. (D) Absorption (red) and emission (black) spectra of TMV-BF3 particles in phosphate buffer; two-photon excitation spectrum (blue) of BF3-NCS in
water; a.u., arbitrary units; GM, Goeppert-Mayer units. (E,F) Electrophoretic analysis of the size-purified TMV-BF3 particles under denaturing conditions. (E)
Coomassie blue-stained SDS-PAGE gel showing the presence of CP (17.6 kD, asterisk). (F) Same gel as in E but analyzed with a fluorescence scanner equipped with
a sypro2 filter. A fluorescent band at approximately 18.5 kD is detected and confirms the presence of BF3-coupled CP. The orange dye conjugated to the 70 kDa
protein of the size ladder (Thermo Scientific) also exhibits fluorescence under the illumination conditions used. The occurrence of fluorescence below the BF3-CP band
suggests that the bond between BF3 and CP is partially sensitive to the denaturating SDS-PAGE conditions. (G) TP-FCS analysis of TMV-BF3 particles under native
conditions showing a long diffusion time of 0.75ms corresponding to the labeled viral particle (>95%) and a shorter time of 0.024ms corresponding to free dye (<5%).
biodegradable and thus provide a safe platform for biomedical
applications. Because of their anisotropic shape and their size,
the particles may provide a sensitive probe to measure blood
flow. In addition, large dyes also play a role as probes in
other cases of brain diagnostics such as the optical mapping
of damages to the BBB. The BBB consists of a tightly packed
layer of endothelial cells that acts as a physical barrier between
the blood vessels and the central nervous system and prevents
many substances from diffusing across it (Rubin and Staddon,
1999). Disruption of the BBB causing leakage of substances
from the blood vessels into the brain is a serious condition
that occurs in many pathological conditions such as brain
tumors (Jain, 1987; Dvorak et al., 1988; Hashizume et al., 2000),
brain injuries (McDannold et al., 2008; Moretti et al., 2015),
infections of the central nervous system (Lossinsky and Shivers,
2004), neurological diseases such as multiple sclerosis (Patel
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FIGURE 2 | Intravital imaging of the mouse brain vasculature with
TMV-BF3 particles. (A) Mouse brain vessels labeled with TMV-BF3 at 1 h
after intravenous injection into the tail vein. (B) Same observation window as
shown in (A) but after a second injection, this time with sulforhodamine B;
blue, fluorescence emitted from TMV-BF3; red, fluorescence emitted from
sulforhodamine B. The 3D projections were performed with Fiji software using
the standard deviation projection method.
and Frey, 2015), Parkinson’s diseases (Lee and Pienaar, 2014),
or stroke (Gartshore et al., 1997; Latour et al., 2008). BBB
openings allowing leakage can also be induced by radiotherapy
or drugs (e.g., nicotine; Manda et al., 2010), or by physical
factors such highly focused ultrasound (Yang et al., 2014) or
blast-associated pressure waves (Kabu et al., 2015). The proper
mapping of blood supply to brain regions affected by BBB
leakage requires large dyes to label the leaky vessels without
important diffusion into the extravascular space, which would
otherwise lead to an overestimation of the functional blood
volume supply and blur two-photonmicroscopic images (Maurin
et al., 2011). Small dyes such as sulforhodamine B, but also
the well-established blood pool dye 70 kDa rhodamine-labeled
dextran with a hydrodynamic radius of 6 nm, and even the largest
dextrans (200 kDa) with a hydrodynamic radius of 27 nm are
known to diffuse across leaky vessels (Jain, 1987; Dvorak et al.,
1988; Vérant et al., 2008; Maurin et al., 2011). Large dyes such
as TMV-BF3 also have potential to contribute to the imaging
of primary brain tumors, in particular glioblastomas, which
are among the most therapy-resistant tumors. The combined
application of both large dyes, such as TMV-BF3, and small
diffusible dyes as probes for multi-photon deep tissue imaging
of the healthy and diseased brain may represent a promising
approach for exploring changes in transport barriers and for
distinguishing between normal and functional vessels with a
leaky BBB that are important for drug supply during tumor
growth. VNPs such as TMV-BF3 may also be further developed
to deliberately cross the BBB and thus to deliver therapeutics to
the diseased brain (Meyers et al., 2013).
The application of TMV particles for vascular and other
in vivo imaging applications will have to await further
improvements. Our preliminary in vivo data indicate that large
TMV particles may obstruct the blood perfusion in some micro-
vessels probably due to the formation of aggregates at low blood
flow. Thus, TMV particles of different sizes should be tested
to optimize the particle size for specific in vivo biomedical
applications. This is straightforward since CP assembles in vitro
into small 34-mers (disks, 20 S particles) or, in the presence of
RNA carrying the OAS, to larger particles with sizes determined
by the size of RNA template (Fraenkel-Conrat and Williams,
1955; Okada, 1986; Butler, 1999; Klug, 1999). It should be
considered also that TMV is ubiquitously present in the
environment and that most if not all mammals and humans carry
TMV-specific antibodies in their blood streams. Thus, although
compatible with blood, TMV is usually cleared rapidly from
blood by liver and spleen (Bruckman et al., 2014). However, this
may actually provide an advantage over inorganic particles, as
TMV particles prone to rapid clearance after application may
prevent potential side effects. Recurrent administrations may
prolong their application if needed. To increase the half-life
of circulation of TMV within the blood vessels, the particle
may also be coated with polyethylene glycol (PEG), which will
minimize molecular interactions with the particle surface and
thus recognition by the immune system (Raja et al., 2003;
Steinmetz and Manchester, 2009; Bruckman et al., 2014). On
the other hand, the coupling of BF3 to TMV may already
increase TMV half-life in the blood, since it was shown that
the grafting of a molecule similar in size to BF3 inhibited the
elicitation of an antibody response (Wei et al., 2014). This effect
could be enhanced by the presence of oligoethylene chains at
the periphery of the fluorophore, thus rendering the particle
even more furtive. It will have to be seen whether and in as
much the circulation half-life, biodistribution, and clearance
mechanisms of TMV-BF3 particles will be influenced by their
final shape, size, and surface properties, as shown for other
nanoparticles (Geng et al., 2007; Gratton et al., 2008; Li and
Huang, 2008; Arnida et al., 2011; Longmire et al., 2011; Sa et al.,
2012).
The utilization of plant VNPs for intravital vascular imaging
was previously demonstrated with particles of Cowpea mosaic
virus (CPMV; Lewis et al., 2006). However, unlike in our current
study, one-photon dyes were used and fixation and sectioning
were required for deep tissue imaging in adult mice. Moreover,
the icosahedral particles of CPMV do not provide flexibility
in particle design like TMV. Interestingly, the fluorochrome-
tagged CPMV particles did not remain within vessels but entered
the vessel endothelium. Although such feature may contribute
to the long-term stability of the fluorescence signal, it also
limits application in blood flow measurements and may also
enhance the risk of leakage across the BBB. In addition to
CPMV and TMV, many other plant viruses are being investigated
as VNPs for applications in medicine (Steinmetz et al., 2010;
Yildiz et al., 2010; Wen et al., 2012; Shukla et al., 2014). For
example, CPMV and other plant viruses, like Cowpea chlorotic
mottle virus (CCMV), and also bacteriophages such as MS2
and Qβ, are explored as platforms for the binding of several
hundred contrast agents in order to improve the efficiency
of magnetic resonance imaging (MRI; Liepold et al., 2007).
Combining these or fluorescent plant VNPs (e.g., TMV-BF3)
with specific targeting ligands and therapeutic agents such as
drugs or peptides may lead to the development of novel cost-
effective tools for in vivo imaging and treatment approaches that
may eventually revolutionize the current concepts of diagnosis
and therapy.
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